The Silverstein Foundation In the News
The Silverstein Foundation has been featured in national and international publications and broadcast media. Explore the thinks below to see and hear what others are saying about the Foundation and our Founder’s story.
BusinessWire: The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics
August, 2017—The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. (“REGENXBIO”), and OrbiMed today announced the formation and launch of Prevail Therapeutics, Inc., (“Prevail”), a new company focused on discovering and developing novel...
FierceBiotech: Silverstein-backed startup will test gene therapy for Parkinson’s
August, 2017—Regenxbio has joined forces with investment firm OrbiMed and a new nonprofit foundation to create Prevail Therapeutics, a startup focused on new biologics and gene therapies for Parkinson’s disease (PD).
The relationship between glucocerebrosidase mutations and Parkinson disease, Migdalska-Richards et. al.
The Globes Israel (in Hebrew)
לנסותלא-אוותר-בלי-לנסות-להציל-את-חיי